Potentials and limitations of microorganisms as renal failure biotherapeutics.
Renal insufficiency leads to uremia, a complicated syndrome. It thus becomes vital to reduce waste metabolites and regulate water and electrolytes in kidney failure. The most common treatment of this disease is either dialysis or transplantation. Although these treatments are very effective, they are extremely costly. Recently artificial cells, microencapsulated live bacterial cells, and other cells have been studied to manage renal failure metabolic wastes. The procedure for microencapsulation of biologically active material is well documented and offers many biomedical applications. Microencapsulated bacteria have been documented to efficiently remove urea and several uremic markers such as ammonia, creatinine, uric acid, phosphate, potassium, magnesium, sodium, and chloride. These bacteria also have further potential as biotherapeutic agents because they can be engineered to remove selected unwanted waste. This application has enormous potential for removal of waste metabolites and electrolytes in renal failure as well as other diseases such as liver failure, phenylketonuria, and Crohn's disease, to name a few. This paper discusses the various options available to date to manage renal failure metabolites and focuses on the potential of using encapsulated live cells as biotherapeutic agents to control renal failure waste metabolites and electrolytes.
Jain
Poonam
P
Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Physiology, Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, Montreal, Québec, Canada.
Shah
Sapna
S
Coussa
Razek
R
Prakash
Satya
S
Am J Kidney Dis. 1996 Dec;28(6):943-50
8957051
Biotechnol Bioeng. 1988 Jul 20;32(3):363-8
18584759
Biomater Artif Cells Artif Organs. 1989;17(4):403-11
2605354
Biotechnol Appl Biochem. 1990 Jun;12(3):227-36
1694439
Biomater Artif Cells Immobilization Biotechnol. 1993;21(5):629-36
8117852
Artif Cells Blood Substit Immobil Biotechnol. 1994;22(1):vii-viii
8055093
Int J Artif Organs. 1991 Apr;14(4):239-41
2060989
ASAIO J. 2004 May-Jun;50(3):253-60
15171478
Can J Physiol Pharmacol. 1969 Dec;47(12):1043-5
5360363
Trends Biotechnol. 1999 Feb;17(2):61-7
10087605
Artif Cells Blood Substit Immobil Biotechnol. 2003 Nov;31(4):425-34
14672417
Mol Med Today. 1998 May;4(5):221-7
9612802
Int J Artif Organs. 1990 Jul;13(7):404-6
2401576
Int J Artif Organs. 1987 Jul;10(4):269-74
3666978
Tissue Eng. 2004 Sep-Oct;10(9-10):1446-55
15588404
Biotechnol Annu Rev. 1995;1:267-95
9704091
J Am Soc Nephrol. 1998 Oct;9(10):1924-30
9773794
Blood Purif. 2000;18(2):91-6
10838466
J Biomed Biotechnol. 2005;2005(1):44-56
15689638
Kidney Int Suppl. 1976 Dec;(7):S211-4
1070535
Med J Aust. 1973 May 12;1(19):926-30
4715399
Science. 1964 Oct 23;146(3643):524-5
14190240
Hepatology. 1990 Dec;12(6):1342-9
2258150
Methods Mol Biol. 1997;63:343-58
9113661
ASAIO Trans. 1991 Apr-Jun;37(2):80-7
1649615
Int J Artif Organs. 2000 Jul;23(7):429-35
10941635
Artif Organs. 1992 Feb;16(1):8-12
1338616
Artif Cells Blood Substit Immobil Biotechnol. 1996 May;24(3):201-18
8773740
Biotechnol Bioeng. 1985 Feb;27(2):146-50
18553649
Clin Nephrol. 1979 Feb;11(2):81-5
378490
Dig Dis Sci. 1991 Sep;36(9):1320-6
1893819
Nat Med. 1996 Jun;2(6):696-9
8640564
Trans Am Soc Artif Intern Organs. 1977;23:726-9
910409
J Clin Invest. 1958 Dec;37(12):1818-35
13611050
Am J Kidney Dis. 1988 Aug;12(2):97-103
3400639
Hum Gene Ther. 1999 Jan 1;10(1):49-59
10022530
Artif Cells Blood Substit Immobil Biotechnol. 2000 Sep;28(5):397-408
11009112
Kidney Int Suppl. 1976 Dec;(7):S269-72
1070545
Semin Liver Dis. 1986 May;6(2):164-73
3018936
N Engl J Med. 1974 Jan 3;290(1):39-49
4808500
Trans Am Soc Artif Intern Organs. 1981;27:24-30
7036498
Science. 1986 Sep 12;233(4769):1190-2
2426782
Proc Eur Dial Transplant Assoc. 1972;9:514-20
4668924
Nat Med. 1996 Aug;2(8):883-7
8705857
Kidney Int Suppl. 1976 Dec;(7):S273-6
1070546
Ann N Y Acad Sci. 2001 Nov;944:362-72
11797686
Appl Biochem Biotechnol. 1984;10:27-40
6524933
Lancet. 1994 Oct 15;344(8929):1046-9
7934445
Biotechnol Bioeng. 1995 Jun 20;46(6):621-6
18623357
Methods Enzymol. 1988;137:444-57
3374352
Ann N Y Acad Sci. 1990;613:109-15
2075970
Kidney Int Suppl. 1976 Dec;(7):S266-8
1070544
Trans Am Soc Artif Intern Organs. 1972;18(0):458-64, 484
4679903
Trans Am Soc Artif Intern Organs. 1966;12:13-9
5960694
Artif Cells Blood Substit Immobil Biotechnol. 1998 Jan;26(1):35-51
9507755
Artif Cells Blood Substit Immobil Biotechnol. 1999 Sep-Nov;27(5-6):475-81
10595451
Ann N Y Acad Sci. 1997 Dec 31;831:249-59
9616717